Gladstone land corp (LAND)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
ASSETS
Real estate, at cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

217,283

185,973

169,933

148,371

117,118

90,394

79,121

78,478

44,866

44,323

39,678

39,678

Less: accumulated depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,078

5,482

4,943

4,431

-

-

-

3,166

-

-

-

-

Less: accumulated depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,934

3,587

3,426

-

2,978

2,818

2,670

2,535

Real Estate Investment Property, Net

799,456

792,081

740,608

587,969

541,451

538,953

497,068

463,274

458,915

449,486

444,390

405,222

379,499

326,311

309,237

268,581

249,983

221,783

211,205

180,490

164,989

143,940

113,184

86,807

75,694

75,311

41,887

41,505

37,008

37,143

Lease intangibles, net

4,001

4,827

5,257

5,039

5,364

5,686

5,829

5,078

5,328

5,492

5,796

5,905

1,872

2,000

2,115

2,033

2,225

1,763

1,931

2,069

1,679

1,317

761

641

284

311

182

192

183

208

Cash and cash equivalents

30,232

13,688

3,992

28,705

23,108

14,730

2,929

2,583

2,679

2,938

3,758

2,766

2,473

2,438

2,396

2,077

2,193

2,532

2,701

3,158

2,180

2,619

3,031

3,829

13,546

16,271

39,377

42,405

29,074

873

Crop inventory

-

-

-

-

-

-

0

0

2,059

1,528

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs related to borrowings under line of credit, net

-

-

-

-

-

-

-

-

-

-

209

217

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs related to borrowings under line of credit, net

-

-

-

-

-

-

-

-

-

-

209

217

225

-

128

124

-

132

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

132

2

1

0

0

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

680

680

680

680

680

680

20,676

679

Deferred financing costs related to borrowings under line of credit, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

128

-

1,174

1,142

1,048

1,039

996

812

557

309

294

301

308

304

Deferred offering costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

133

290

-

134

139

122

-

-

-

-

1,006

Other assets, net

7,431

6,191

7,170

7,010

6,026

5,750

4,070

4,276

3,935

2,834

2,407

2,910

2,913

3,236

2,429

2,368

2,439

2,472

1,976

2,221

1,915

2,653

1,831

857

735

789

3,279

3,120

2,761

770

TOTAL ASSETS

841,120

816,787

757,027

628,723

575,949

565,119

509,896

475,211

472,916

462,278

456,560

417,020

386,982

333,985

316,306

275,185

256,970

228,684

219,190

189,215

172,103

151,702

120,621

93,771

91,623

93,673

85,701

88,205

90,013

40,985

LIABILITIES AND EQUITY
LIABILITIES:
Borrowings under lines of credit

100

100

4,100

100

100

100

100

3,500

3,900

10,000

5,100

35,050

20,050

16,550

22,500

14,500

2,800

100

5,000

2,800

11,800

4,000

3,500

3,000

100

100

100

100

100

100

Notes and bonds payable, net

477,426

481,829

448,004

350,144

333,835

335,788

316,142

289,924

289,050

291,002

290,234

236,941

220,720

190,797

167,879

165,973

156,928

141,578

135,085

107,661

94,866

82,417

53,845

41,331

41,331

43,054

29,489

29,489

29,489

30,717

Series A cumulative term preferred stock, $0.001 par value, $25.00 per share liquidation preference; 2,000,000 shares authorized, 1,150,000 shares issued and outstanding as of March 31, 2020, and December 31, 2019, net

28,418

28,359

28,301

28,241

28,183

28,124

28,066

28,007

27,948

27,890

27,831

27,773

-

27,655

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A cumulative term preferred stock, par value $0.001 per share; $25.00 per share liquidation preference; 2,000,000 shares authorized, 1,150,000 shares issued and outstanding as of March 31, 2017, and December 31, 2016, net

-

-

-

-

-

-

-

-

-

-

-

-

27,714

-

27,601

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

8,733

10,132

7,015

9,134

6,715

9,152

6,400

9,958

8,575

7,398

4,382

4,684

2,596

2,801

2,222

3,945

4,746

3,495

2,701

2,882

2,391

1,925

928

676

1,035

1,097

669

634

674

913

Due to related parties, net

2,921

2,169

1,194

364

676

945

1,024

807

950

940

984

836

980

751

636

736

628

565

539

630

117

471

448

314

309

160

64

-

-

104

Due to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

74

155

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

743

743

258

743

Other liabilities, net

15,467

15,228

15,123

9,386

11,671

9,957

10,964

7,864

10,525

7,097

9,043

7,260

8,974

7,654

8,921

7,802

8,427

4,937

4,846

3,341

3,753

2,919

2,109

1,391

901

749

310

492

343

269

Total liabilities

533,065

537,817

503,737

397,369

381,180

384,066

362,696

340,060

340,948

344,327

337,574

312,544

281,034

246,208

229,761

192,957

173,530

150,677

148,172

117,315

112,928

91,733

60,831

46,714

43,678

45,161

31,376

31,534

31,021

32,849

Commitments and contingencies (Note 7)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

EQUITY:
Stockholders’ equity:
Preferred stock, value

6

5

3

3

2

1

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, $0.001 par value; 65,522,353 shares authorized 21,346,458 shares issued and outstanding as of March 31, 2020; 91,514,600 shares authorized, 20,936,658 shares issued and outstanding as of December 31, 2019

21

21

21

21

18

18

16

16

15

14

13

12

12

10

10

9

9

9

9

9

7

7

7

6

6

6

6

6

6

2

Additional paid-in capital

348,020

315,770

286,562

263,249

223,480

202,053

163,943

155,106

145,990

129,705

126,848

109,020

109,012

90,082

89,374

87,494

87,494

86,892

79,146

79,148

65,361

65,366

-

-

-

-

-

-

-

-

Accumulated other comprehensive loss

-1,647

-390

-347

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Distributions in excess of accumulated earnings

40,701

38,785

35,344

31,919

28,731

25,826

22,305

25,763

21,950

19,802

-

-

-

13,402

-

-

-

8,895

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,545

51,326

51,326

51,326

51,326

51,326

51,326

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-17,801

-15,941

-14,621

-

-12,197

-10,988

-9,860

-

-8,138

-7,257

-6,194

-5,404

-4,763

-4,276

-3,387

-2,820

2,992

5,338

7,659

8,133

Total stockholders’ equity

305,699

276,621

250,895

231,354

194,769

176,246

141,654

129,359

124,055

109,917

109,060

93,091

94,403

76,690

77,187

76,515

77,644

78,006

71,017

71,900

59,174

59,969

59,789

47,056

47,945

48,511

54,325

56,671

58,991

8,136

Non-controlling interests in Operating Partnership

2,356

2,349

2,395

0

0

4,807

5,546

5,792

7,913

8,034

9,926

11,385

11,545

11,087

9,357

5,711

5,795

0

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

308,055

278,970

253,290

231,354

194,769

181,053

147,200

135,151

131,968

117,951

118,986

104,476

105,948

87,777

86,545

82,227

83,440

78,006

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL LIABILITIES AND EQUITY

841,120

816,787

757,027

628,723

575,949

565,119

509,896

475,211

472,916

462,278

456,560

417,020

386,982

333,985

316,306

275,185

256,970

228,684

219,190

189,215

172,103

151,702

120,621

93,771

91,623

93,673

85,701

88,205

90,013

40,985